CoChat

SIRT3 inhibits prostate cancer by destabilizing oncoprotein c-MYC through regulation of the PI3K/Akt pathway

Open access
Quan, Yizhou, Wang, Naitao, Chen, Qianqian, Xu, Jin, Cheng, Wei, Di, Meijuan, Xia, Weiliang, Gao, Wei-Qiang · 2015 · Oncotarget
Cited by 76

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

// Yizhou Quan 1 , Naitao Wang 1 , Qianqian Chen 1 , Jin Xu 1 , Wei Cheng 2 , Meijuan Di 3 , Weiliang Xia 1 and Wei-Qiang Gao 1,4 1 State Key Laboratory of Oncogenes and Related Genes, Renji-MedX Clinical Stem Cell Research Center, Ren Ji Hospital, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China 2 Department of Urology, First People’s Hospital of Xiaoshan, Hangzhou, Zhejiang, China 3 Department of Pathology, First People’s Hospital of Xiaoshan, Hangzhou, Zhejiang, China 4 Collaborative Innovation Center of Systems Biomedicine, Shanghai, China Correspondence to: Weiliang Xia, email: // Wei-Qiang Gao, email: // Keywords : SIRT3, prostate cancer, oncoprotein, PI3K-Akt pathway, c-MYC Received : March 23, 2015 Accepted : June 25, 2015 Published : July 03, 2015 Abstract SIRT3 is involved in aging-related diseases including cancer, but its role in prostate cancer and detailed regulatory function are not known. We found that SIRT3 was moderately down-regulated in prostate carcinomas. Overexpression of SIRT3 by lentiviral transfection inhibited prostate cancer growth both in vitro and in vivo , whereas knockdown of SIRT3 increased prostate tumor growth. Mechanistically, the tumor suppression effect of SIRT3 was achieved via its inhibition of the PI3K/Akt pathway. Notably, upregulation of SIRT3 suppressed the phosphorylation of Akt, leading to the ubiquitination and degradation of oncoprotein c-MYC; this could be attenuated by constitutive activation of PI3K/Akt signaling. Collectively, our results unveiled SIRT3’s tumor suppressive function and the underlying mechanism in prostate cancer, which might provide therapeutic implications for the disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.4764

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 76

Metadata

Authors
Quan, Y., Wang, N., Chen, Q., Xu, J., Cheng, W., Di, M., Xia, W., & Gao, W.-Q.
Venue
Oncotarget
Published
2015-07-03
Volume
6
Issue
28
Pages
26494-26507
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1606861223
Cited by
76
References
9
FWCI
3.50
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.